Precision Molecular

Precision Molecular is owned by D&D Pharmatech. D&D Pharmatech has a direct presence in 3 countries.

They are in:

• Biotechnology67%
• Pharmaceuticals33%

View the org chart displaying its 6 main executives

Most searched biographies at Precision Molecular

• Seulki Lee, Chief Executive Officer
• Don Ho, Director of Intellectual Property
• Jacob Kim, Assciate Director of Accounting & Finance

Create your alert
to follow the executive moves at Precision Molecular.

D&D Pharmatech has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Precision Molecular

• General 2 — Precision Molecular

Social media about Precision Molecular

• Precision Molecular on Wikipedia, Google News & Yahoo Finance
• Precision Molecular on LinkedIn, Twitter & YouTube

Contact by email its executives including Jacob Kim

Call Precision Molecular at +1 613...

View the org chart

Register to receive your alert

Report an error